West-ward 3125 (Hydrochlorothiazide 12.5 mg)
Pill imprint West-ward 3125 has been identified as Hydrochlorothiazide 12.5 mg.
Hydrochlorothiazide is used in the treatment of high blood pressure; edema; diabetes insipidus; nephrocalcinosis; osteoporosis and belongs to the drug class thiazide diuretics. There is no proven risk in humans during pregnancy. Hydrochlorothiazide 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- West-ward 3125
- Strength:
- 12.5 mg
- Color:
- Blue
- Size:
- 15.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Thiazide diuretics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- West-Ward Pharmaceutical Corporation
- National Drug Code (NDC):
- 00143-3125
- Inactive Ingredients:
- silicon dioxide colloidal
corn starch
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68071-0255 | Nucare Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More about hydrochlorothiazide
Consumer resources
- HCTZ
- Hydrochlorothiazide
- Hydrochlorothiazide capsules
- Hydrochlorothiazide solution
- Hydrochlorothiazide (Advanced Reading)
- Other brands: Microzide, Aquazide H
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
